Financhill
Back

Madrigal Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:
$430.90
Seasonality Move:
-8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Madrigal Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 51.1% based on the past 19 years of stock performance.
  • Madrigal Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
  • Is Madrigal Pharmaceuticals, Inc. Stock Undervalued?
    The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $436.87. The Score for MDGL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Madrigal Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 51.1% based on the past 19 years of stock performance.

Madrigal Pharmaceuticals, Inc. Stock Rating

Sell
40
Madrigal Pharmaceuticals, Inc. (MDGL) is a Sell

Is Madrigal Pharmaceuticals, Inc. overpriced?

  • Madrigal Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Madrigal Pharmaceuticals, Inc. Stock Price History

Is MDGL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com

52-Week Data

52-Week High:
615.00
52-Week Low:
265.00

Prediction Charts

Market Cap:
9.9B
Price in USD:
436.87
Volume:
1.2M
Beta:
1.08

Technical Analysis

SMA50:
526.21
SMA100:
505.48
SMA200:
421.32
52-Wk Change:
27.13%

Stock Predictions

  • Is Madrigal Pharmaceuticals, Inc. stock public?
    Yes, Madrigal Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Madrigal Pharmaceuticals, Inc. stock quote today?
    The Madrigal Pharmaceuticals, Inc. stock price is 436.87 USD today.
  • How to buy Madrigal Pharmaceuticals, Inc. stock online?
    You can buy Madrigal Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-30 489.75 489.31 497.54 480.02
Feb-2 483.11 489.73 497.73 481.02
Feb-3 486.17 482.45 491.29 467.86
Feb-4 478.75 478.61 482.06 472.52
Feb-5 478.90 463.42 486.88 458.00
Feb-6 475.69 477.60 482.88 465.20
Feb-9 477.60 488.26 490.50 471.39
Feb-10 488.30 478.83 499.55 475.34
Feb-11 483.03 481.00 483.03 463.53
Feb-12 483.90 473.79 484.25 468.08
Feb-13 474.31 464.71 482.99 458.07
Feb-17 462.37 487.32 495.00 462.04
Feb-18 486.71 491.49 498.10 480.00
Feb-19 452.02 436.87 461.98 427.78

Madrigal Pharmaceuticals, Inc. Earnings

Madrigal Pharmaceuticals, Inc. Earnings Report: Per Share Madrigal Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Madrigal Pharmaceuticals, Inc. Forecast Revenue Growth

Madrigal Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $3.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.17 per share, and an increase next year of $14.50 per share.

* Madrigal Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.